✦ LIBER ✦

Muscle strength in early Parkinson's disease

✍ Scribed by Hiroshi Nogaki; Toshihiro Fukusako; Fujio Sasabe; Kiyoshi Negoro; Mitsunori Morimatsu

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 218 KB
Volume: 10
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870100218

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Speech dysfunction in early Parkinson's

Speech dysfunction in early Parkinson's disease

✍ Dr. Celia Stewart; Linda Winfield; Ann Hunt; Susan B. Bressman; Stanley Fahn; An 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 1 views

## Abstract The purpose of this study is to determine if subjects in the early stages of untreated Parkinson's disease (PD) or PD treated with deprenyl alone suffer from motor speech abnormalities. Speech defects are common in advanced PD, including distrubances of respiration, phonation, and artic

Cognitive decline in early Parkinson's d

Cognitive decline in early Parkinson's disease

✍ Nagaendran Kandiah; Kaavya Narasimhalu; Puay-Ngoh Lau; Soo-Hoon Seah; Wing Lok A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

## Abstract Data on the prevalence and severity of cognitive impairment among patients with newly diagnosed idiopathic Parkinson's disease (PD) is limited. Using a prospectively collected clinical database, we studied the longitudinal trend of mini‐mental state examination (MMSE) change and baselin

Levodopa response in early Parkinson's d

Levodopa response in early Parkinson's disease

✍ Robert A. Hauser; Peggy Auinger; David Oakes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks

Early dopamine agonist therapy in Parkin

Early dopamine agonist therapy in Parkinson's disease

✍ Prof. U. K. Rinne 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 1 views

GCH1 in early-onset Parkinson's disease

✍ Stephanie A. Cobb; Christian Wider; Owen A. Ross; Ignacio F. Mata; Charles H. Ad 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract Mutations in __GTP‐cyclohydrolase 1__ (__GCH1__) cause autosomal dominant dopa‐responsive dystonia (DRD), characterized by childhood‐onset foot dystonia that later generalizes. DRD patients frequently present with associated Parkinsonism. Conversely, early‐onset Parkinson's disease (EOP

Bradykinesia, muscle weakness and reduce

Bradykinesia, muscle weakness and reduced muscle power in Parkinson's disease

✍ Natalie E. Allen; Colleen G. Canning; Catherine Sherrington; Victor S.C. Fung 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract Muscle power (force × velocity) could clarify the relationship between weakness and bradykinesia in Parkinson's disease (PD). The aims of this study were to determine if patients with PD were weaker and/or less powerful in their leg extensor muscles than a neurologically normal control